[go: up one dir, main page]

WO1997007220A3 - Linker insertion mutagenesis by means of the transposition system of insertion sequence is21 - Google Patents

Linker insertion mutagenesis by means of the transposition system of insertion sequence is21 Download PDF

Info

Publication number
WO1997007220A3
WO1997007220A3 PCT/EP1996/003625 EP9603625W WO9707220A3 WO 1997007220 A3 WO1997007220 A3 WO 1997007220A3 EP 9603625 W EP9603625 W EP 9603625W WO 9707220 A3 WO9707220 A3 WO 9707220A3
Authority
WO
WIPO (PCT)
Prior art keywords
linker
mutagenesis
transposition system
proteins
sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP1996/003625
Other languages
German (de)
French (fr)
Other versions
WO1997007220A2 (en
Inventor
Dieter Haas
Thomas Seitz
Bernard Berger
Sergio Schmid
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Roche Diagnostics GmbH
Original Assignee
Boehringer Mannheim GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim GmbH filed Critical Boehringer Mannheim GmbH
Publication of WO1997007220A2 publication Critical patent/WO1997007220A2/en
Publication of WO1997007220A3 publication Critical patent/WO1997007220A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/10Processes for the isolation, preparation or purification of DNA or RNA
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/10Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/102Mutagenizing nucleic acids
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70Vectors or expression systems specially adapted for E. coli
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10Transferases (2.)
    • C12N9/1003Transferases (2.) transferring one-carbon groups (2.1)
    • C12N9/1018Carboxy- and carbamoyl transferases (2.1.3)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

A genetic engineering process allows 4 to 11 codons to be inserted into any site of cloned genes. In genes that code for proteins, the reading pattern is not modified by an insertion. The insertions modify the protein structure, so that the proteins may be given a modified biologic activity. Transposition may be carried out according to this process both in vivo, for example in Escherichia coli, or in vitro. The process may also be used to insert epitopes.
PCT/EP1996/003625 1995-08-18 1996-08-16 Linker insertion mutagenesis by means of the transposition system of insertion sequence is21 Ceased WO1997007220A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH237395 1995-08-18
CH2373/95-3 1995-08-18

Publications (2)

Publication Number Publication Date
WO1997007220A2 WO1997007220A2 (en) 1997-02-27
WO1997007220A3 true WO1997007220A3 (en) 1997-03-20

Family

ID=4232259

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP1996/003625 Ceased WO1997007220A2 (en) 1995-08-18 1996-08-16 Linker insertion mutagenesis by means of the transposition system of insertion sequence is21

Country Status (1)

Country Link
WO (1) WO1997007220A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2829986B1 (en) 2001-09-26 2003-12-26 Roulements Soc Nouvelle ELECTRIC POWER ASSISTED STEERING SYSTEM

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
BACTERIAL CONJUGATION (CLEWELL, D., ed.), PLENUM PRESS, New York, 1993; Chapter 6; REIMMANN, C. & HAAS, D.:'Mobilization of chromosomes and nonconjugative plasmids bycointegrative mechanisms.' *
Diss. ETH Nr. 10197. ZÜRICH 1993. SCHMID, S.:'Die Insertionssequenz IS21: Entwicklung eines In-vitro Integrationssystems' *
HOEKSTRA, M. ET AL.: "A Tn3 derivative that can be used to make short in-frame insertions within genes", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA, vol. 88, June 1991 (1991-06-01), WASHINGTON US, pages 5457 - 5461, XP002024153 *

Also Published As

Publication number Publication date
WO1997007220A2 (en) 1997-02-27

Similar Documents

Publication Publication Date Title
NZ243500A (en) Nucleic acid encoding dihydrokaempferol hydroxylating enzyme (dhk) and its use in producing transgenic flowering plants
AU568067B2 (en) Oligonucleotide therapeutic agent and methods of making same
AU7550098A (en) System for expressing hyperthermostable protein
ES8705521A1 (en) A METHOD OF PRODUCING A TUMOR NECROSIS FACTOR (TNF) SIMILAR FROM MAMMALS.
NZ335945A (en) Presenilin proteins and genetic sequences that are related to Alzheimer's disease
DE69839401D1 (en) Dcr3 polypeptid, ein tnfr homolog
CA2200371A1 (en) Human npik gene
NZ504214A (en) Recombination cloning using nucleic acids having recombination sites
SI0917571T1 (en) Agouti-related gene
HUT46061A (en) Dna sequences encoding hirudin-like protein and process for producing such proteins
GR1005153B (en) Fusion proteins their preparation and use
WO1998021343A8 (en) Genes encoding telomerase proteins
ES2191011T3 (en) NUCLEIC ACID, EXPRESSION VECTOR AND COMPOSITIONS FOR THE IDENTIFICATION AND SYNTHESIS OF RECOMBINANT SIALILTRANSPHERASES.
WO1995003328A3 (en) Melanoma-inhibiting protein
WO1994005791A3 (en) Dorsal tissue affecting factor and compositions
MX9806041A (en) PURIFIED SR-p70 PROTEIN.
AU3475495A (en) Process for producing recombinant proteins, plasmids and modified cells
WO1997007220A3 (en) Linker insertion mutagenesis by means of the transposition system of insertion sequence is21
AU7949991A (en) Cloned n-methylhydantoinase
WO1998027200A3 (en) Human and mammalian dna replication origin consensus sequences
BG101556A (en) New derivatives of staphylokinase
EP0263553A3 (en) Method of inhibiting gene induction
WO1998003653A3 (en) Method for preparing transgenic non-human mammalian organs for transplantation to humans, and nucleotide sequences therefor
SE9503379D0 (en) A modified GAD, a method for producing a modified GAD, a method for providing a modified GAD, a peptide and the use of an ordinary and / or a modified GAD
MX9708877A (en) 'delta'p62, variants thereof, nucleic acid sequences and uses thereof.

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): JP US

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE

AK Designated states

Kind code of ref document: A3

Designated state(s): JP US

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase